Growth hormone secretagogues typically improve sleep quality within the first week
*Variable with missing
Barlow S, Chesson A, Collins J et al (2005) Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic
These mechanisms may support musculoskeletal repair, gastrointestinal healing, and reduced systemic inflammation, although results differ from person to person
NICE-approved weight management interventions include: Dietary and lifestyle modification first-line approach for all patients Orlistat licensed medication for obesity (BMI 30 or 28 with comorbidities) GLP-1 receptor agonists including semaglutide (Wegovy) per NICE TA875 and liraglutide (Saxenda) with restrictions per NICE TA664, for specific patient groups Bariatric surgery for severe obesity meeting strict criteria The NHS emphasises that sustainable weight loss requires behavioural change, nutritional education, and increased physical activity
Outside the US it is supplied as a research-grade peptide and is not approved for human use by any major regulator